Merle P

References (2)

Title : First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561\/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers - Harding_2022_Liver.Cancer_11_268
Author(s) : Harding JJ , Awada A , Roth G , Decaens T , Merle P , Kotecki N , Dreyer C , Ansaldi C , Rachid M , Mezouar S , Menut A , Bestion EN , Paradis V , Halfon P , Abou-Alfa GK , Raymond E
Ref : Liver Cancer , 11 :268 , 2022
Abstract :
PubMedSearch : Harding_2022_Liver.Cancer_11_268
PubMedID: 35949290

Title : GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer - Brun_2021_J.Cancer_12_5432
Author(s) : Brun S , Pascussi JM , Gifu EP , Bestion E , Macek-Jilkova Z , Wang G , Bassissi F , Mezouar S , Courcambeck J , Merle P , Decaens T , Pannequin J , Halfon P , Caron de Fromentel C
Ref : J Cancer , 12 :5432 , 2021
Abstract :
PubMedSearch : Brun_2021_J.Cancer_12_5432
PubMedID: 34405006